News & Updates
-
OCRA Earns 4-Star Charity Navigator Rating for Ninth Consecutive Year
(February 5, 2019) OCRA is pleased to announce we have earned our NINTH consecutive 4-star rating from Charity Navigator, America’s largest independent charity evaluator…
-
New Therapeutic Approaches for Mucinous Ovarian Cancer
(February 13, 2019) Data from a study conducted by researchers at MD Anderson and Johns Hopkins suggest that an adjuvant gastrointestinal (GI)-based chemotherapy regimen is more beneficial than one…
-
OCRA Awards $5.25 Million in Scientific Research Grants for 2019
(January 10, 2019) We’re pleased to announce OCRA’s newest research grants of $5.25 million to 23 top scientists at 14 top medical centers…
-
OCRA Funded Research Delves Deeper into How PARPi Work
(December 21, 2018) This month, researchers in Boston published their findings on how PARP inhibitors (PARPi) cause a chain reaction of responses from the tumor and its environment…
-
FDA Approves Olaparib for Frontline Maintenance Treatment in Ovarian Cancer
(December 20, 2018) Earlier this year a phase III clinical trial, known as SOLO-1, showed that frontline olaparib (Lynparza) can reduce the risk of disease progression or death by up to 70% in women…
-
Turn Up the Heat: Celebrating DC’s Female Culinary Superstars
Foodies Unite! OCRA invites you to indulge in the culinary talents of DC’s top female chefs, restaurateurs and mixologists on March 5th as we Turn Up the Heat to end ovarian cancer! For one…
Help Save Women's Lives
Our Impact
-
Invested over $85M
in ovarian cancer research since 1998
-
Educated 75,000+
future medical professionals since 2002
-
Advocated for $150M+
in government research funding in 2018
Fundraise for OCRA
-
Do It Yourself
Create your own unique fundraiser to help end ovarian cancer.
-
Ovarian Cycle
Start or join an Ovarian Cycle® ride in your town and spin for a cure!
Check out our calendar for an upcoming event near you!